Peptides DB
Research-centric peptide and protocol reference hub
Study 23 of 24P21 (P021) literaturebiorxiv-preprint · Observational2026

Genotoxic and metabolic stress drive divergent senescence programs in human microglia

Chronic genotoxic and metabolic stress induce different senescence programs in human microglia, which may have implications for neurodegenerative diseases.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the p21 (p021) corpus
6
Preclinical
18
Observational · this one
0
Open-label
0
Randomised
0
Reviews

Summary and findings

This study investigated the effects of chronic genotoxic and metabolic stress on senescence-associated phenotypes in the human microglia cell line HMC3. Cells were exposed to doxorubicin or high-glucose conditions, leading to characteristic senescence features. Both stressors activated the p53-p21 pathway and induced inflammatory responses.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Microglial dysfunction is a hallmark of brain ageing linked to the accumulation of senescent microglial phenotypes that promote chronic neuroinflammation. Both genotoxic and metabolic stress have been implicated in microglial senescence; yet, whether distinct stressors shape senescence programs remain unclear. Here, we investigated the impact of chronic genotoxic and metabolic stress on senescence-associated phenotypes in the human microglia cell line HMC3. Cells were exposed to doxorubicin to induce sustained DNA damage or to chronic high-glucose conditions to model metabolic stress. Both stress paradigms induced characteristic senescence features including cellular and nuclear hypertrophy, increased senescence-associated β galactosidase activity and reduced metabolic viability without significant cell loss. Both conditions activated the p53-p21 pathway and sustained DNA damage signalling, whereas metabolic stress additionally induced p16 expression and peripheral nuclear localisation of p21, suggesting divergence in senescence regulatory pathways. Mitochondrial alterations were evident under both conditions, Dox-induced stress was associated with downregulation of NRF2-TFAM signalling, whereas HG-induced stress induced NRF2-TFAM activation alongside increased KEAP1 expression, suggesting a constrained antioxidant response. This was accompanied by activation of mitochondrial and antioxidant stress responses that did not restore mitochondrial content. Furthermore, both stressors induced robust inflammatory activation, with genotoxic stress promoting a chemokine-rich senescence-associated secretory phenotype, while metabolic stress induced an interferon-associated inflammatory signature. Collectively, these findings demonstrated that chronic genotoxic and metabolic stress drive distinct yet overlapping senescence programs characterised by morphological changes, mitochondrial remodelling and persistent inflammatory activation. These stress-specific responses may differentially contribute to neurodegenerative processes and disease susceptibility.

Background

The study appears to address the effects of genotoxic and metabolic stress on senescence programs in human microglia. Understanding these processes is important as microglial senescence may play a role in neurodegenerative diseases. The title suggests a focus on divergent pathways, which could have implications for therapeutic strategies targeting microglial aging.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the P21 (P021) corpus

CA tumour-derived organoid biobank maps cancer gene dependencies.Nature · 2026In vitroCCholesterol and p53 promote senescence and systemic fibrosis in metabolic dysfunction-associated steatohepatitisbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCCell cycle control of chromatin creates a therapeutic window for epigenetic therapy in tumorsbiorxiv-preprint · 2026 · Not reported in abstract.In vitroCPunicalagin alleviates senile osteoporosis by inhibiting the senescence of bone mesenchymal stem cells via NRF2/HO-1 pathway.Regenerative therapy · 2026 · Not reported in abstract.AnimalBPrognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer.Annals of medicine · 2026 · HR > 1.1, p < 0.001 for RiskScore as an independent predictor of overall survival.HumanDDaraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.The New England journal of medicine · 2026